SENSE_NATURE: Weather Sensitivity and the Effects of Walking in Nature on Stress Response of Individuals With Coronary Artery Disease

Sponsor
Lithuanian University of Health Sciences (Other)
Overall Status
Recruiting
CT.gov ID
NCT06139705
Collaborator
(none)
160
1
2
15
10.7

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to investigate how walking in different environments affects the psychophysiological responses to the stress of individuals with coronary artery disease (CAD) according to their weather sensitivity. Awareness about the potential influence of weather sensitivity on the psychophysiological reactions to stress in patients with CAD disease may contribute to the planning and implementation of actions leading to improved medical care services and preventative measures that help to avoid the worsening of health and well-being in the future.

Condition or Disease Intervention/Treatment Phase
  • Other: Walking outdoor
  • Other: Walking indoor
N/A

Detailed Description

The environment might influence one's course of a disease and health prospective through direct exposure to physical, chemical, social, and psychosocial risk factors, as well as indirectly, through behavior-related changes response to those factors. Classical risk factors only partially account for variations in the occurrence, incidence, and mortality of cardiovascular disease (CVD). Therefore, other, less-explored factors need to be taken in consideration when referring to CVD epidemiology.

The main goal of this clinical trial is to investigate how walking in different environments affects the psychophysiological responses to the stress of individuals with coronary artery disease (CAD) during rehabilitation. An experimental study will be carried out including individuals with CAD attending cardiac rehabilitation. The hypothesis is that psychophysiological reactions to stress in weather-sensitive (WS) individuals with CAD will differ from non-WS individuals when walking outdoors (in a natural environment).

To achieve the main goal, the following specific tasks will be implemented:
  1. To determine how walking in a natural environment affects the psychophysiological reactions to stress in individuals with CAD.

  2. To determine how walking in the gym affects the psychophysiological reactions to stress in individuals with CAD.

  3. To analyse the associations between the psychophysiological reactions to stress of individuals with CAD and the walking environment, considering the sensitivity to the weather.

  4. To determine the connections between mental flexibility and weather sensitivity.

The participants will be randomly assigned to either walking outdoors (OUT) or walking indoors (IN) groups. OUT group will walk in natural environment (in the park) along a pre-designated route. IN group will walk in a gym on a treadmill. The order and sequence of measurements within each trial will be the same. During both interventions, the participants will be supervised by investigators.

The idea is to increase knowledge about the impact of the natural environment on well-being and health and to provide more information to health professionals and the public. Awareness about the potential influence of weather sensitivity on the psychophysiological reactions to stress in patients with CAD disease may contribute to the planning and implementation of actions leading to improved medical care services and preventative measures that help to avoid the worsening of health and well-being in the future. Protective measures should be directed towards susceptible groups rather than the population. The outcomes of this experiment may have direct clinical applications for the use of different types of environments in cardiac rehabilitation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
After baseline measurements, the patients will be randomly assigned to either walking outdoors (OUT) or walking indoors (IN) groups. OUT group will walk in the parke. IN group will walk in a gym on a treadmill. During both interventions, the patient will be supervised by researchers. The order and sequence of measurements within each trial will be the same.After baseline measurements, the patients will be randomly assigned to either walking outdoors (OUT) or walking indoors (IN) groups. OUT group will walk in the parke. IN group will walk in a gym on a treadmill. During both interventions, the patient will be supervised by researchers. The order and sequence of measurements within each trial will be the same.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Weather Sensitivity Profile and the Effects of Walking in Nature on Psychophysiological Stress Response in Individuals With Coronary Artery Disease
Actual Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Aug 31, 2024
Anticipated Study Completion Date :
Aug 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Walking outdoors group (OUT group)

The OUT group will walk in natural environment.

Other: Walking outdoor
The individuals will walk in park along a pre-designated route 20 min.

Experimental: Walking indoors group (IN group)

The IN group will walk indoors.

Other: Walking indoor
The individuals will walk in a gym on a treadmill 20 min.

Outcome Measures

Primary Outcome Measures

  1. Psychophysiological respond to stress [Two days]

    The primary outcome is psychophysiological reaction to stress. Psychophysiological stress responses will be assessed by hemodynamic parameters and cortisol level. concentration in saliva. Hemodynamic parameters will be measured using a long-term blood pressure device, which simultaneously, continuously, and non-reactively records blood pressure, ECG, and oxygen saturation, allowing comparative analysis of several vital parameters. A long-term BP monitor will be placed on the participant in the morning, duration of measurement up to 24 hours. Cortisol levels will be measured from saliva. Saliva samples will be obtained from participants using saliva sampling tubes. Samples will then be stored at -70 zero of Celsius and cortisol levels will be determined in a licensed laboratory using commercial reagent kits. Saliva samples will be taken five times: two times a day before experiment, three times - during experiment. One sampling procedure duration up to 2 min.

Secondary Outcome Measures

  1. Weather sensitivity [up to 5 minutes]

    To assess weather sensitivity, individuals will be filled in Palanga self-assessment diary for weather sensitivity (PSAD-WS). PSAD-WS is an 11-item (general) three-factor tool for collecting information regarding weather sensitivity in patients with CAD. The three subscales reflected 1) psychological symptoms, 2) cardiac symptoms and 3) physical. Also, individuals will be asked a single question: "Do you feel the weather changes?" with possible answers of "NO" or "YES".

  2. Mental flexibility [up to 60 minutes]

    Mental flexibility will be evaluated using Cambridge Neuropsychological Test Automated Battery (CANTAB). CANTAB evaluate alterations in executive function. Specifically, the following tests is used: Motor screening Task - sensorimotor function; Cambridge Gambling Test - decision making (impulsivity, risk taking); Delayed Matching to Sample - short-term visual recognition memory; Intra-Extra Dimensional Set Shift - set-shifting, mental flexibility; Match to Sample Visual Search - attention and visual searching; One Touch Stockings - spatial planning and the working memory; Rapid Visual Information Processing - sustained attention; Spatial Working Memory - working memory.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. from 18 years and older,

  2. diagnosis of CAD,

  3. participation in the cardiac rehabilitation program,

  4. able to hear, speak and read in Lithuanian, and

  5. signed informed consent.

Exclusion Criteria:
  1. coronary artery bypass graft surgery, other cardiac surgery graft,

  2. cognitive or communicative disabilities or other severe comorbidities,

  3. unstable cardiovascular status,

  4. did not speak Lithuanian fluently,

  5. did not consent in participating

Contacts and Locations

Locations

Site City State Country Postal Code
1 Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences Palanga Lithuania 00135

Sponsors and Collaborators

  • Lithuanian University of Health Sciences

Investigators

  • Principal Investigator: Nijole Kazukauskiene, Dr., Lithuanians Uiversity of Health Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dalia Martinaitiene, Principal Investigator, Lithuanian University of Health Sciences
ClinicalTrials.gov Identifier:
NCT06139705
Other Study ID Numbers:
  • BE-2-9
  • S-MIP-23-114
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dalia Martinaitiene, Principal Investigator, Lithuanian University of Health Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2023